z-logo
open-access-imgOpen Access
Immunotherapy with a biologically active ICAM-1 mAb and an siRNA targeting TSHR in a BALB/c mouse model of Graves’ disease
Author(s) -
Xuan Wang,
Wei Liu,
Zhongying Rui,
Wei Zheng,
Jian Tan,
Ning Li,
Yang Yu
Publication year - 2021
Publication title -
endokrynologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.a2021.0087
Subject(s) - monoclonal antibody , medicine , antibody , thyroid , pharmacology , graves' disease , immunotherapy , icam 1 , immunology , endocrinology , immune system , cell adhesion molecule
The objective was to study targeted therapies using a biologically active monoclonal antibody against intracellular adhesion molecule-1 (ICAM-1 mAb) and an siRNA targeting thyroid-stimulating hormone (TSH) receptor (TSHR) in a BALB/c mouse model of Graves' disease (GD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here